Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$112M in Q4 2021 → $24.7M now. Hover for any quarter.
As reported for the quarter ended September 30, 2022. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Twist Bioscience Corp | 44.0% | Unchanged | 307,740 | $10.8M |
| SB Selecta Biosciences Inc | 25.2% | Trimmed 5.4% | 3,787,515 | $6.21M |
| Icosavax Inc | 17.5% | Trimmed 22% | 1,361,658 | $4.3M |
| Sqz Biotechnologies Co | 13.4% | Unchanged | 1,445,221 | $3.3M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2022 · filed November 09, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icosavax Inc | Trimmed | −374,256 | −$1.18M | 17.5% |
| SB Selecta Biosciences Inc | Trimmed | −215,000 | −$353K | 25.2% |
quarter ended June 30, 2022 · filed July 28, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icosavax Inc | Trimmed | −957,858 | −$5.49M | 32.6% |
| SB Selecta Biosciences Inc | Added | +354,608 | +$465K | 17.2% |
quarter ended March 31, 2022 · filed May 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icosavax Inc | Trimmed | −56,222 | −$396K | 41.6% |
Loading...
